Related references
Note: Only part of the references are listed.Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy
David Yarnitsky et al.
PAIN (2012)
Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison
Robert J. Tanenberg et al.
MAYO CLINIC PROCEEDINGS (2011)
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Howard N. Bockbrader et al.
CLINICAL PHARMACOKINETICS (2010)
Pregabalin and Gabapentin in Matched Patients With Peripheral Neuropathic Pain in Routine Medical Practice in a Primary Care Setting: Findings From a Cost-Consequences Analysis in a Nested Case Control-Study
Concepcion Perez et al.
CLINICAL THERAPEUTICS (2010)
A review of SSRIs and SNRIs in neuropathic pain
Yee-Chi Lee et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities
Maija L. Haanpaa et al.
MAYO CLINIC PROCEEDINGS (2010)
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
Robert H. Dworkin et al.
MAYO CLINIC PROCEEDINGS (2010)
An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy
Che S. Zin et al.
CNS DRUGS (2008)
Pregabalin in the Treatment of Refractory Neuropathic Pain: Results of a 15-Month Open-Label Trial
Brett R. Stacey et al.
PAIN MEDICINE (2008)
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Robert H. Dworkin et al.
PAIN (2007)
Diabetic peripheral neuropathy and depressive symptoms
L Vileikyte et al.
DIABETES CARE (2005)
Cyclic antidepressants and the risk of sudden cardiac death
WA Ray et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
M Backonja et al.
CLINICAL THERAPEUTICS (2003)
Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents
HW Cohen et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
